The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. Novavax shares jumped 35% in premarket trade. The award is the biggest
[Source: news.yahoo.com] [ Comments ] [See why this is trending]